Track Tandem Diabetes Care, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Tandem Diabetes Care, Inc. TNDM Open Tandem Diabetes Care, Inc. in new tab

18.61 USD
EPS
-3.04
P/B
8.19
ROE
-97.89
Beta
1.67
Target Price
30.76 USD
Tandem Diabetes Care, Inc. logo

Tandem Diabetes Care, Inc.

🧾 Earnings Recap – Q3 2025

Tandem Diabetes Care reported record Q3 sales, driven by significant advancements in commercial operations and successful product launches, positioning the company for future growth.

  • Record Q3 sales driven by improved sales productivity and an effective commercial transformation in the U.S.
  • Successful launch of t:slim X2 with Abbott's FreeStyle Libre 3 Plus integration, enhancing user access to advanced diabetes management technology.
  • Expansion of Type 2 diabetes efforts showing promising results, doubling the company's addressable market in the U.S.
  • Direct sales initiatives in Europe slated to begin in early 2026, enhancing growth potential and margin expansion.
  • Increased pharmacy benefit coverage for Tandem Mobi reaching over 40% of U.S. lives, marking a significant milestone in revenue generation.
📅
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateApril 29, 2026
EPS-3.04
Book Value2.27
Price to Book8.19
Debt/Equity289.60
% Insiders0.685%
Growth
Revenue Growth0.03%
Estimates
Forward P/E-984.14
Forward EPS-0.02
Target Mean Price30.76

DCF Valuation

Tweak assumptions to recompute fair value for Tandem Diabetes Care, Inc. (TNDM)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Tandem Diabetes Care, Inc. Logo Tandem Diabetes Care, Inc. Analysis (TNDM)

United States Health Care Official Website Stock

Is Tandem Diabetes Care, Inc. a good investment? Tandem Diabetes Care, Inc. (TNDM) is currently trading at 18.61 USD. Market analysts have a consensus price target of 30.76 USD. This suggests a potential upside from current levels.

Earnings Schedule: Tandem Diabetes Care, Inc. is expected to release its next earnings report on April 29, 2026. The market consensus estimate for Forward EPS is -0.02.

Investor FAQ

Does Tandem Diabetes Care, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Tandem Diabetes Care, Inc.?

Tandem Diabetes Care, Inc. is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be April 29, 2026. The company currently has a trailing EPS of -3.04.

Company Profile

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Exchange Ticker
NMS (United States) TNDM
LSE (United Kingdom) 0M0F.L
FRA (Germany) TD5A.F

Dividends

Historical Split Corporate Actions

Split Date Split Ratio to 1
Oct. 10, 2017 0.100000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion